Skip to Content

Join the 'Pre-Exposure Prophylaxis' group to help and get support from people like you.

Pre-Exposure Prophylaxis News

Related terms: Pre-Exposure Prophylaxis HIV Infection, PrEP, Reducing Risk of HIV Infection

Newer HIV Therapies Yield Big Gains But Racial Gaps Persist

Posted 13 minutes ago by Drugs.com

TUESDAY, Aug. 21, 2018 – Improved treatment has nearly tripled viral suppression rates among HIV patients in the United States over the past two decades, researchers report. But viral suppression rates remain lower among young people and black Americans, the researchers add. About 1.2 million U.S. adults have HIV, the virus that causes AIDS. Achieving and maintaining suppression of the virus is ...

New Drug of Last Resort, Ibalizumab, Tackles Resistant HIV

Posted 5 days ago by Drugs.com

THURSDAY, Aug. 16, 2018 – HIV, the virus that causes AIDS, is typically a manageable infection, but medications that keep the virus at bay don't work for everyone. Now, researchers have developed a new medication to help them. The U.S. Food and Drug Administration approved the drug – ibalizumab (Trogarzo) – in March. Phase 3 trial results were published in the Aug. 16 issue of the New England ...

HIV Doubles Heart Disease Risk

Posted 30 Jul 2018 by Drugs.com

MONDAY, July 30, 2018 – People with HIV are twice as likely to develop heart disease than those without the AIDS-causing virus, British researchers report. Their review of studies from 153 countries also found that HIV-associated heart disease has more than tripled in the past 20 years, as more people with HIV live longer. More than two-thirds of HIV-associated heart disease occurs in ...

AHA: The Link Between HIV and High Blood Pressure

Posted 18 May 2018 by Drugs.com

FRIDAY, May 18, 2018 (American Heart Association) – People with HIV are more likely than people without the virus to have high blood pressure, in part because of treatments and repercussions of the condition itself, a new review of research shows. Learning more about the underlying mechanisms of high blood pressure in people with HIV is critical in preventing one of the leading conditions that ...

FDA Approves Expanded Indication for Truvada (emtricitabine and tenofovir disoproxil fumarate) for Reducing the Risk of Acquiring HIV-1 in Adolescents

Posted 16 May 2018 by Drugs.com

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 15, 2018-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Truvada (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)—in combination with safer sex practices—to reduce the risk of sexually acquired HIV-1 in at-risk adolescents. The safety and efficacy profile of Tru ...

HIV Drug, Tenofovir, Appears Safe During Pregnancy

Posted 26 Apr 2018 by Drugs.com

WEDNESDAY, April 25, 2018 – Drugs to prevent HIV-positive pregnant women from infecting their unborn babies appear safe and don't raise the risk for premature birth or infant death, new research indicates. The U.S. scientists said their findings should ease worries among expectant mothers treated with antiviral regimens that contain the drug tenofovir disoproxil fumarate (TDF). "The analysis ...

Scientists Zero in on Better Saliva-Based HIV Test

Posted 29 Jan 2018 by Drugs.com

MONDAY, Jan. 29, 2018 – An experimental saliva-based HIV test shows promise, researchers report. The new test may be able to detect early evidence of HIV antibodies in saliva as reliably as a blood test, according to the scientists who developed it. The antibodies are produced by the immune system to fight HIV, the virus that causes AIDS. "The earlier you can detect, the better, because people ...

U.S. Efforts to Help Fight Global HIV Are Paying Off

Posted 25 Jan 2018 by Drugs.com

WEDNESDAY, Jan. 24, 2018 – A U.S. government program to prevent, treat and care for people with HIV/AIDS in poor countries has been highly effective and should continue, experts say. Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has provided drug therapy to more than 13 million men, women and children, as well as voluntary circumcisions to more than 15.2 million men to ...

HIV Is Gaining Resistance to Lifesaving Drugs

Posted 1 Dec 2017 by Drugs.com

FRIDAY, Dec. 1, 2017 – A new study warns of a potential return to the "bad old days" when there were no effective drugs to fight HIV, the virus that causes AIDS. Timed for release on Dec. 1, World AIDS Day, the new study looked at data on more than 56,000 adults living with HIV in sub-Saharan Africa, Asia and Latin America. In total, patients in 63 low- and middle-income countries were screened, ...

U.S.-Funded HIV Prevention Effort Reaps Rewards in Uganda

Posted 30 Nov 2017 by Drugs.com

THURSDAY, Nov. 30, 2017 – A program that includes male circumcision and antiviral drug treatment led to a sharp drop in HIV infection rates in a high-risk region of Uganda, researchers report. Their study of a U.S.-funded HIV prevention program in the rural Rakai District on the shore of Lake Victoria followed 34,000 people. The program provides a number of free services, including anti-HIV ...

HIV Diagnoses Occurring More Quickly, CDC Says

Posted 28 Nov 2017 by Drugs.com

TUESDAY, Nov. 28, 2017 – U.S. health care providers are getting better at detecting new cases of HIV infection, although it still can take years for people to know they've acquired the dreaded virus, federal officials reported Tuesday. The average time between HIV infection and diagnosis was three years in 2015, seven months earlier than it had been in 2011, according to researchers from the ...

Pot May Alter Brain Function of Some With HIV

Posted 28 Nov 2017 by Drugs.com

MONDAY, Nov. 27, 2017 – Using marijuana when you have HIV could lead to problems with brain function if you also abuse alcohol or drugs, a new study finds. "People with HIV infection have many reasons to have cognitive dysfunction, from the virus itself to medications for HIV infection and related conditions, particularly as they age," said lead researcher Richard Saitz. He's a professor and ...

Almost 21 Million Worldwide Now Have Access to HIV Meds

Posted 21 Nov 2017 by Drugs.com

TUESDAY, Nov. 21, 2017 – The number of people with HIV who take life-saving antiretroviral medications has increased by tens of millions worldwide in recent decades, a United Nations report says. The number rose from 685,000 in 2000 to 20.9 million as of June 2017, according to UNAIDS, the Joint United Nations Program on HIV and AIDS. "Many people do not remember that in 2000 there were only 90 ...

Are HIV and AIDS Poised for a Comeback?

Posted 25 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 25, 2017 – The advent of powerful drugs in the mid-1990s brought remarkable gains in survival for HIV patients who had access to the medications. But a team of experts now warns that the global HIV pandemic continues and is at risk of expanding, given the worrisome global rise of HIV resistance to antiretroviral (ART) medications. "Current trends in HIV drug resistance are very ...

Antibody Injections in Pregnancy Might Shield Fetus From Zika

Posted 4 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 4, 2017 – A new antibody "cocktail" promises to provide effective, if temporary, protection against the Zika virus, a new study reports. A blend of three potent antibodies completely prevented Zika infection in a group of four lab monkeys, said senior researcher David Watkins, a professor of pathology with the University of Miami Miller School of Medicine. Regular injections of ...

Page 1 2 3 4 5 6 7 Next

Ask a Question

Further Information

Related Condition Support Groups

HIV Infection

Related Drug Support Groups

Truvada, emtricitabine / tenofovir